| Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry M Bassani-Sternberg, E Bräunlein, R Klar, T Engleitner, P Sinitcyn, ... Nature communications 7 (1), 13404, 2016 | 710 | 2016 |
| Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation*[S] M Bassani-Sternberg, S Pletscher-Frankild, LJ Jensen, M Mann Molecular & Cellular Proteomics 14 (3), 658-673, 2015 | 554 | 2015 |
| Large‐scale identification of leaf senescence‐associated genes S Gepstein, G Sabehi, MJ Carp, T Hajouj, MFO Nesher, I Yariv, C Dor, ... The Plant Journal 36 (5), 629-642, 2003 | 471 | 2003 |
| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 438 | 2020 |
| Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes C Chong, M Müller, HS Pak, D Harnett, F Huber, D Grun, M Leleu, ... Nature communications 11 (1), 1293, 2020 | 293 | 2020 |
| Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity M Bassani-Sternberg, C Chong, P Guillaume, M Solleder, HS Pak, ... PLoS computational biology 13 (8), e1005725, 2017 | 267 | 2017 |
| Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes J Racle, J Michaux, GA Rockinger, M Arnaud, S Bobisse, C Chong, ... Nature biotechnology 37 (11), 1283-1286, 2019 | 261 | 2019 |
| Antitumour dendritic cell vaccination in a priming and boosting approach A Harari, M Graciotti, M Bassani-Sternberg, LE Kandalaft Nature Reviews Drug Discovery 19 (9), 635-652, 2020 | 234 | 2020 |
| High-throughput and sensitive immunopeptidomics platform reveals profound interferonγ-mediated remodeling of the human leukocyte antigen (HLA) ligandome C Chong, F Marino, HS Pak, J Racle, RT Daniel, M Müller, D Gfeller, ... Molecular & Cellular Proteomics 17 (3), 533-548, 2018 | 213 | 2018 |
| Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer F Coscia, E Lengyel, J Duraiswamy, B Ashcroft, M Bassani-Sternberg, ... Cell 175 (1), 159-170. e16, 2018 | 170 | 2018 |
| Predicting antigen presentation—what could we learn from a million peptides? D Gfeller, M Bassani-Sternberg Frontiers in immunology 9, 1716, 2018 | 167 | 2018 |
| Mass spectrometry-based antigen discovery for cancer immunotherapy M Bassani-Sternberg, G Coukos Current opinion in immunology 41, 9-17, 2016 | 164 | 2016 |
| Identification of tumor antigens with immunopeptidomics C Chong, G Coukos, M Bassani-Sternberg Nature Biotechnology 40 (2), 175-188, 2022 | 162 | 2022 |
| The length distribution and multiple specificity of naturally presented HLA-I ligands D Gfeller, P Guillaume, J Michaux, HS Pak, RT Daniel, J Racle, G Coukos, ... The Journal of Immunology, 2018 | 161 | 2018 |
| The SysteMHC atlas project W Shao, PGA Pedrioli, W Wolski, C Scurtescu, E Schmid, JA Vizcaíno, ... Nucleic acids research 46 (D1), D1237-D1247, 2018 | 151 | 2018 |
| Soluble plasma HLA peptidome as a potential source for cancer biomarkers M Bassani-Sternberg, E Barnea, I Beer, I Avivi, T Katz, A Admon Proceedings of the National Academy of Sciences 107 (44), 18769-18776, 2010 | 144 | 2010 |
| Unsupervised HLA peptidome deconvolution improves ligand prediction accuracy and predicts cooperative effects in peptide–HLA interactions M Bassani-Sternberg, D Gfeller The Journal of Immunology 197 (6), 2492-2499, 2016 | 142 | 2016 |
| Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting J Schmidt, AR Smith, M Magnin, J Racle, JR Devlin, S Bobisse, J Cesbron, ... Cell Reports Medicine 2 (2), 2021 | 132 | 2021 |
| Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment A Newey, B Griffiths, J Michaux, HS Pak, BJ Stevenson, A Woolston, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 129 | 2019 |
| Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome MBS Roman Mylonas, Ilan Beer, Christian Iseli, Chloe Chong, HuiSong Pak ... Molecular and cellular Proteomics, 2018 | 112 | 2018 |
